Undergraduate

FDA’s current regulatory framework assures highest safety standards for vaccines but drives a vaccine development to commercial delivery timeline of on average of 6-7 years from initial clinical study start. Some extraordinary events such as bioterrorism threats or pandemics can expedite the process. The speaker will discuss real-world experience with urgent development and stockpile of the smallpox vaccine.